Areas of Research
There will not be a single answer to epidermolysis bullosa. Each type of EB presents different challenges and presents a challenge to the technologies employed. The complexity of body systems affected will necessitate combination therapy, as in cancer treatment. Research therefore has to be focused on cell, gene, protein and drug therapies that aim to tackle the damage caused by EB externally and internally and treat the aggressive malignant skin cancer that can develop in early adulthood and is always terminal.